Time courses of improvement and symptom remission in children treated with atomoxetine for attention-deficit/hyperactivity disorder: analysis of Canadian open-label studies

BACKGROUND: The relatively short durations of the initial pivotal randomized placebo-controlled trials involving atomoxetine HCl for the treatment of attention-deficit/hyperactivity disorder (ADHD) provided limited insight into the time courses of ADHD core symptom responses to this nonstimulant, se...

Descripción completa

Detalles Bibliográficos
Autores principales: Dickson, Ruth A, Maki, Ellen, Gibbins, Christopher, Gutkin, Stephen W, Turgay, Atilla, Weiss, Margaret D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120776/
https://www.ncbi.nlm.nih.gov/pubmed/21569378
http://dx.doi.org/10.1186/1753-2000-5-14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120776/
https://www.ncbi.nlm.nih.gov/pubmed/21569378
http://dx.doi.org/10.1186/1753-2000-5-14

Ejemplares similares